[Herald Economy (仁川) = Reporter Hongseok Lee] The 仁川经济自由区厅 held the '2019 Asia Pain Symposium' at 松岛 Convensia on the 6th.
The Asia Pain Symposium is the largest 生物制药 networking event ever held in 松岛, bringing together more than 500 experts in basic research, clinical practice, and 制药s in the field of innovative 新药开发 for pain.
The symposium featured presentations by world-class scholars in pain-related fields, including Xu Zhang, Director of the Institute of Neuroscience at the Chinese Academy of Sciences; Professor Jianguo G. Gu of the University of Alabama at Birmingham School of Medicine; Professor Makoto Tominaga of the Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, 日本; Professor Jinmo Jeong of the University of Texas Medical Branch; and Director Outaek Hwang of the Brain Science Institute at the 韩国 Institute of Science and Technology.
Top-level academic and medical professionals from Asia's leading pain societies — including the 日本ese Pain Society, the Chinese Society of Neuroscience, and the Hong Kong Society of Pain Specialists — also attended.
IFEZ Deputy Commissioner Byeongyun Yoo said in his opening remarks, "Researchers are the agents of innovative growth in the bio industry," and noted that events like the Asia Pain Symposium help researchers quench their thirst for information exchange and research collaboration.